[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_5178 

# __Inadequate evaluation of drug therapies for covid-19__

## Articles mentionning the risk

* [Barcelo_environmental_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_407.md)

## Mitigations of this risk

* [Thorough clinical trials and evaluation of drug therapies before widespread use](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_7051.md)

## Name of the risk

Use of ineffective or harmful drugs to treat COVID-19 patients

## People affected by this risk

* [And researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_121.md)
* [Covid-19 patients](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_501.md)
* [Healthcare providers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2680.md)

## Stakeholders who can mitigate this risk

* [And regulatory authorities](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_413.md)
* [Pharmaceutical companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_124.md)
* [Research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_3199.md)

## Technologies linked to the risk

* [Clinical trial protocols and evidence-based evaluations](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_6274.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Lack of effective medical solutions](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_37.md)

